GLP1R
GLP1R 분자 정보
| 영어 이름 | Glucagon-like peptide-1 | 시판 약물 수 | 0 |
| 임상 약물 수 | 13 | 표적 별명 | GLP-1 |
| 최고 연구 개발 단계 | Phase 3 Clinical | ||
| 영어 이름 | Glucagon-like peptide-1 |
| 표적 별명 | GLP-1 |
| 시판 약물 수 | 0 |
| 임상 약물 수 | 13 |
| 최고 연구 개발 단계 | Phase 3 Clinical |
GLP1R 제품 목록
- 속성
Protein (6)Cell (5)
- 제품 라이브러리
온라인 (11)
- 종
Human (11)
- 태그
His Tag (1)His Tag & Avi Tag (1)Fc Tag (1)- (6)His Tag & Flag Tag (1)His Tag & Avi Tag & Flag Tag (1)
- 마커
Unconjugated (4)Biotin-labeled (2)- (5)
| 제품 번호 | 종 | 발현 시스템 | 제품 설명 | 단백질 구조 | 순도 | 특성 |
|---|---|---|---|---|---|---|
 Human | HEK293 | Human GLP-1R (Luc) HEK293 Reporter Cell |  | |||
| Human | HEK293 | HEK293/Human GLP-1R Stable Cell Line (High Expression) | | |||
| Human | HEK293 | Human GLP1R Protein, Fc Tag, low endotoxin (MALS verified) |  |  |  | |
| Human | HEK293 | Biotinylated Human GLP1R Protein, His,Avitag™ (HPLC verified) |  | | | |
| Human | HEK293 | Human GLP-1R (GFP) HEK293 Reporter Cell | | |||
| Human | HEK293 | HEK293/Human GLP-1R Stable Cell Line (Medium Expression) | | |||
| Human | HEK293 | HEK293/Human GLP-1R Stable Cell Line (Low Expression) | | |||
| Human | HEK293 | Human GLP1R Full Length Protein (L260F), Flag,His Tag (Detergent) |  | | ||
| Human | HEK293 | Human GLP1R Protein, His Tag, low Endotoxin (MALS verified) |  | | | |
| Human | HEK293 | Human GLP1R Full Length Protein (VLP) | |
총 수량11
- 1
- 2
GLP1R분자 배경
G-protein coupled receptor for glucagon-like peptide 1 (GLP-1). Ligand binding triggers activation of a signaling cascade that leads to the activation of adenylyl cyclase and increased intracellular cAMP levels. Plays a role in regulating insulin secretion in response to GLP-1
GLP1R분자 별명
GLP-1-R, GLP-1R, glucagon like peptide 1 receptor
임상 약물 정보
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| BioGlutide | NA-931 | Phase 3 Clinical | Biomed Industries Inc | Body Weight; Body Weight Changes; Diabetes Mellitus; Diabetes Mellitus, Type 2; Obesity; Overweight; Weight Loss | 상세 |
| Bionetide | NA-921 | Phase 3 Clinical | Biomed Industries Inc | Fragile X Syndrome; Rett Syndrome | 상세 |
| ZT-006 | ZT-006; ZT006 | Phase 2 Clinical | Beijing QL Biopharmaceutical Co Ltd | Alzheimer Disease; Body Weight; Diabetes Mellitus; Diabetes Mellitus, Type 2; Obesity; Overweight | 상세 |
| HM-15275 | HM15275; HM-15275 | Phase 2 Clinical | Hanmi Pharmaceutical Co Ltd | Obesity | 상세 |
| SYH-2082 | SYH-2082; SYH2082 | Phase 1 Clinical | Beijing Kangchuanglian Biopharmaceutical Technology Research Co Ltd | Obesity; Overweight | 상세 |
| SNA-003 | SNA003; SNA-003 | Phase 1 Clinical | SN BioScience | Diabetes Mellitus; Obesity | 상세 |
| CA-111 | CA-111; CA111 | Phase 1 Clinical | Chongqing Chenan Biopharmaceutical Co Ltd | Body Weight | 상세 |
| ACT-300 | ACT300; ACT-300 | Phase 1 Clinical | Xiamen Amoytop Biotech Co Ltd | Digestive System Diseases; Metabolic Dysfunction-Associated Steatotic Liver Disease | 상세 |
| KAI-4729 | HRS-4729; KAI-4729 | Phase 1 Clinical | Jiangsu Hengrui Medicine Co Ltd | Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity; Overweight | 상세 |
| ZT-003 | ZT003; ZT-003 | Phase 1 Clinical | Beijing QL Biopharmaceutical Co Ltd | Diabetes Mellitus; Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity | 상세 |
| ANY-002 | ANY-002; ANY002 | Phase 1 Clinical | Anya Biopharm Inc | 상세 | |
| KN-069 | KN069; KN-069 | Phase 1 Clinical | Suzhou Alphamab Co Ltd | Metabolic Diseases; Obesity; Overweight | 상세 |
| semaglutide (Lexaria Bioscience) | Clinical | Lexaria Bioscience Corp | Diabetes Mellitus | 상세 |
- 분자 정보
- 제품 목록
- 임상 약물 정보